Transgenic rodents harboring multiple copies of Pmp22 revealed that aberrant Pmp22 expression is linked with CMT1A-associated peripheral neuropathy (6–9) whereas heterozygous knockout of Pmp22 resembled some aspects of HNPP (10). Here, PMP22 is linked to hereditary neuropathy with liability to pressure palsies.